You have 7 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

T1 relaxometry (quantitative T1, qT1)

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Aortic Valve Replacement on Myocardial T1 Values in Severe

Recruiting
  • Aortic Valve Stenosis
  • +4 more
  • Aortic valve replacement
  • Copenhagen O, Denmark
    Rigshospitalet
Jun 15, 2022

nk/T-cell Lymphoma, Newly Diagnosed, Advanced Lymphoma Trial in Beijing (XPO1 inhibitor)

Recruiting
  • nk/T-cell Lymphoma
  • +2 more
  • XPO1 inhibitor
  • Beijing, Haidian, China
    ChinaPLAGH
Apr 18, 2023

NK-T-Cell Lymphoma, Extranodal Trial in Shanghai (4 cycles of ESA regimen with sandwiched radiotherapy, 2 cycles of ESA regimen

Not yet recruiting
  • NK-T-Cell Lymphoma, Extranodal
  • 4 cycles of ESA regimen with sandwiched radiotherapy
  • +2 more
  • Shanghai, Shanghai, China
    Ruijin Hospital
Sep 29, 2023

Breast Cancer, Breast Tumor Trial in Saint Louis (Endocare SlimLine Cryoprobe, Lumpectomy)

Not yet recruiting
  • Breast Cancer
  • Breast Neoplasm
  • Endocare SlimLine Cryoprobe
  • Lumpectomy
  • Saint Louis, Missouri
    Washington University School of Medicine
Aug 15, 2022

Type 1 Diabetes Trial in Seattle (Verapamil)

Completed
  • Type 1 Diabetes
  • Seattle, Washington
    Benaroya Research Institute
Apr 27, 2023

Type 1 Diabetes, Type 2 Diabetes Trial in Tunbridge Wells (Four Week Self-Compassion Course)

Not yet recruiting
  • Type 1 Diabetes
  • Type 2 Diabetes
  • Four Week Self-Compassion Course
  • Tunbridge Wells, United Kingdom
    Salomons Institute for Applied Psychology, Canterbury Christ Chu
Mar 1, 2023

Cancer T1-N0 or T2-N0 of the Oral Cavity Trial in Montpellier (outpatient surgery for T1-N0 or T2-N0 cancers of the oral cavity

Recruiting
  • Cancer T1-N0 or T2-N0 of the Oral Cavity
  • outpatient surgery for T1-N0 or T2-N0 cancers of the oral cavity or oropharynx with lymph node search
  • Montpellier, Hérault, France
    Gui de Chauliac Hospital, ENT Department 80 rue Augustin Fliche
Mar 30, 2022

Advanced Solid Tumor Trial in Beijing (aPD1-MSLN-CAR T Cells)

Not yet recruiting
  • Advanced Solid Tumor
  • αPD1-MSLN-CAR T Cells
  • Beijing, China
    National Cancer Center Cancer Hospital Chinese Academy of Medica
Jul 13, 2023

Trastuzumab Emtansine as Therapy in Chinese HER2 Positive

Not yet recruiting
  • Breast Cancer
  • Trastuzumab emtansine
  • (no location specified)
Jul 13, 2023

Diabetes, Diabetes, Type 1, Lipohypertrophy Trial in Roma (Medtronic Extended Infusion Set)

Completed
  • Diabetes
  • +2 more
  • Medtronic Extended Infusion Set
  • Roma, Italy
    Azienda Ospedaliera San Camillo Forlanini
Oct 6, 2023

Peripheral T-Cell Lymphoma, Not Otherwise Specified, Angioimmunoblastic T-cell Lymphoma Trial in Changchun (Rituximab,

Recruiting
  • Peripheral T-Cell Lymphoma, Not Otherwise Specified
  • Angioimmunoblastic T-cell Lymphoma
  • Changchun, Jilin, China
    The First Bethune Hospital of Jilin University
Apr 7, 2023

Cardiomyopathy, Heart Failure, Coronary Artery Disease Trial in Sydney, Berlin, London

Active, not recruiting
  • Cardiomyopathy
  • +5 more
    • Sydney, New South Wales, Australia
    • +3 more
    Jun 21, 2022

    Overdose Antidote, Bleeding, Allergic Reaction Trial in Ottawa (Autoinjector, Standard Injector, Prefilled)

    Recruiting
    • Overdose Antidote
    • +2 more
    • Autoinjector
    • +2 more
    • Ottawa, Ontario, Canada
      Canadian Forces
    Jul 19, 2022

    Acute Myeloid Leukemia Trial in Fuzhou (CLL1/+CD33 CAR-T)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • CLL1/+CD33 CAR-T
    • Fuzhou, Fujian, China
      Fujian Provincial Children's Hospital
    Jul 10, 2023

    Type 1 Diabetes With Hypoglycemia Trial (DailyDose Smart Snack app, Dexcom G6 CGM)

    Not yet recruiting
    • Type 1 Diabetes Mellitus With Hypoglycemia
    • DailyDose Smart Snack app
    • Dexcom G6 CGM
    • (no location specified)
    Jul 21, 2023

    Hepatocellular Carcinoma Trial in Yichang (Sintilimab)

    Recruiting
    • Hepatocellular Carcinoma
    • Yichang, Hubei, China
      Department of Medical Oncology, Central Hospital of Yichang City
    Sep 1, 2023

    Nasopharyngeal Carcinoma, T2-3N0 or T1-2N1, EBV-DNA=4000 Copy/ml Trial in Guangzhou (Toripalimab, IMRT)

    Recruiting
    • Nasopharyngeal Carcinoma
    • +2 more
    • Guangzhou, Guangdong, China
      Yanqun Xiang
    Feb 7, 2022

    T-cell Acute Lymphoblastic Leukemia, Lymphoblastic T-Cell Lymphoma Trial in Barcelona (CD1a-CAR T)

    Not yet recruiting
    • T-cell Acute Lymphoblastic Leukemia
    • Lymphoblastic T-Cell Lymphoma
    • CD1a-CAR T
    • Barcelona, Spain
    • +1 more
    Jan 10, 2023

    CX3CR1+T Cell Predict Immunotherapy Efficacy

    Recruiting
    • Non-small Cell Lung Cancer
    • PD-1 inhibitor based immunotherapy
    • Changsha, Hunan, China
    • +1 more
    Sep 19, 2023

    Advanced Solid Tumor Trial in Chengdu (Dual-targeting CLDN18.2 and PD-L1 CAR-T cells)

    Not yet recruiting
    • Advanced Solid Tumor
    • Dual-targeting CLDN18.2 and PD-L1 CAR-T cells
    • Chengdu, Sichuan, China
      West China Hospital, Sichuan University
    Oct 9, 2023

    Renal Cell Carcinoma Trial in Sohag (laparoscopic partial nephrectomy)

    Not yet recruiting
    • Renal Cell Carcinoma
    • laparoscopic partial nephrectomy
    • Sohag, Egypt
      Sohag University Hospital
    Aug 3, 2022

    Diabetes, Type 1, Obesity, Childhood, Overweight Trial (Family-Based Treatment for T1D)

    Not yet recruiting
    • Diabetes Mellitus, Type 1
    • +3 more
    • Family-Based Treatment for T1D
    • (no location specified)
    Feb 23, 2023

    Neuroendocrine Tumor (NET), Colorectal Cancer (CRC) Trial (CHM-2101 CAR-T cells)

    Not yet recruiting
    • Neuroendocrine Tumor (NET)
    • Colorectal Cancer (CRC)
    • CHM-2101 CAR-T cells
    • (no location specified)
    Sep 20, 2023

    Solid Tumor Trial (Tumor necrosis factor-thymosin alfa 1 recombinant (TNF-T), Tumor necrosis factor-thymosin alfa 1 recombinant

    Completed
    • Solid Tumor
    • Tumor necrosis factor-thymosin alfa 1 recombinant (TNF-T)
    • Tumor necrosis factor-thymosin alfa 1 recombinant (TNF-T) and chemotherapy
    • (no location specified)
    Jun 8, 2023

    Type1diabetes Trial in Stanford (4T Education and Care)

    Enrolling by invitation
    • Type1diabetes
    • 4T Education and Care
    • Steamboat Springs, Colorado
      Franziska Katherine Bishop
    Dec 5, 2022